Solid cancer patients achieve adequate immunogenicity and low rate of severe adverse events after SARS-CoV-2 vaccination고형암 환자는 SARS-CoV-2 백신 접종 후 적절한 면역원성과 낮은 중증 부작용 발생률 달성Article Published on 2022-07-012022-09-11 Journal: Future Oncology [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, 치료제, [키워드] A significant reduction active treatment Adverse adverse events anti-SARS-CoV-2 S1 IgG antibody antibody level antibody levels anticancer anticancer treatment cancer patient Cancer patients Complete Course COVID-19 disease event healthy controls Immune checkpoint inhibitor Immune checkpoint inhibitors immunogenicity Mild mRNA mRNA-based mRNA-based vaccination mRNA-based vaccine participant Patient patients Prevent receiving Result SARS-CoV-2 vaccination SARS-CoV-2 vaccine second dose Seroconversion seroconversion rate serum severe adverse event severe COVID-19 disease Solid solid cancer therapy Treatment vaccination [DOI] 10.2217/fon-2022-0148 PMC 바로가기 [Article Type] Article
Serological Follow-Up Study Indicates High Seasonal Coronavirus Infection and Reinfection Rates in Early Childhood혈청학적 후속 연구는 유아기에 높은 계절성 코로나바이러스 감염 및 재감염율을 나타냅니다Article Published on 2022-06-292022-09-12 Journal: Microbiology Spectrum [Category] MERS, 진단, [키워드] 229E age analyzed antibodies antibody antibody level Antibody Response caused changes in Characteristics childhood children collected coronavirus Coronavirus infection correlation cross-reactivity declined elicited enzyme enzyme immunoassay Follow-up follow-up study groups HKU1 human coronavirus humoral immune response IgG antibody immunoassay Increased indicated Infection information knowledge NL63 observation OC43 Primary infection Rate Reinfection respiratory infection respiratory infections seasonal seasonal coronavirus serological serology seropositive serum specific antibody specimen spread of COVID-19 suggested the antibody virus were measured [DOI] 10.1128/spectrum.01967-21 PMC 바로가기 [Article Type] Article
Antibody Responses to SARS-CoV-2 in Children With COVID-19COVID-19에 걸린 어린이의 SARS-CoV-2에 대한 항체 반응Article Published on 2022-06-222022-09-11 Journal: Journal of the Pediatric Infectious Diseases Socie [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 age analyzed anti-S IgG anti-SARS-CoV-2 IgG Anti-spike antibody antibody level antibody levels Antibody Response Asymptomatic blood sample Blood samples caused children children with COVID-19 conducted coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 pandemic Cutoff detectable effective evaluate feature geometric mean geometric mean titer geometric mean titers GMT GMTs highest humoral immune response humoral immune responses IgG immune responses immune system Infection longitudinal study neutralizing antibody peaked positive positive rate positive rates reached remained respiratory response SARS-CoV-2 SARS-COV-2 infection severe acute respiratory syndrome Coronavirus South Korea symptom onset symptomatic Vaccine development were measured with COVID-19 [DOI] 10.1093/jpids/piac012 PMC 바로가기 [Article Type] Article
Seroprevalence of Anti-S1-RBD Antibodies in Pre-pandemic and Pandemic Subjects From Hail Region, KSA우박 지역, KSA의 전염병 전 및 전염병 대상체에서 항-S1-RBD 항체의 혈청유병률Article Published on 2022-06-092022-09-11 Journal: Frontiers in Public Health [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술, [키워드] age antibodies antibody level antibody levels Antigen asymptomatic individual Asymptomatic individuals Care clinical and demographic factors clinically collected complications Containment COVID-19 Demographic factors develop Efficacy effort ELISA exhibited exposure to female females group Hail house humoral immune responses identification immune responses in-house ELISA Infection male management neutralizing antibody new SARS-CoV-2 other coronavirus other coronaviruses pandemic positive Protein RBD antigen reduced Region required Research S-RBD S1-RBD Sample SARS-CoV-2 Screen Seroprevalence serum serum antibodies serum antibody serum IgG antibodies serum IgG antibody significantly significantly higher subject Surveillance the SARS-CoV-2 Vaccine variant variants [DOI] 10.3389/fpubh.2022.874741 PMC 바로가기 [Article Type] Article
mRNA or ChAd0x1 COVID-19 Vaccination of Adolescents Induces Robust Antibody and Cellular Responses With Continued Recognition of Omicron Following mRNA-1273청소년의 mRNA 또는 ChAd0x1 COVID-19 예방 접종은 mRNA-1273에 이어 오미크론을 계속 인식하여 강력한 항체 및 세포 반응을 유도합니다Article Published on 2022-06-022022-09-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] Adolescent antibody antibody level antibody levels Antibody Response BNT162b2 CD4+ T-cell Cell cellular response Cellular responses ChAdOx1 comprehensive analysis COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines cytokine develop dominant Donor doses dual elicit Evidence generate health condition High-risk patients IL-10 immune response immune responses immunogenic Infection measure memory Mild mRNA mRNA vaccination mRNA vaccine mRNA-1273 natural infection neuro-disabilities neutralisation titre Neutralisation titres omicron Omicron variant paediatric physical populations reactivity Recognition remained response risk robust severe disease significantly increased single vaccination Strong T-cell T-cell Response T-cell responses T-cells These data vaccination Vaccine vaccine dose variant [DOI] 10.3389/fimmu.2022.882515 PMC 바로가기 [Article Type] Article
Longitudinal analysis of anti-SARS-CoV-2 S-RBD IgG antibodies before and after the third dose of the BNT162b2 vaccineBNT162b2 백신의 3차 접종 전후에 항-SARS-CoV-2 S-RBD IgG 항체의 종단적 분석Article Published on 2022-05-232022-09-12 Journal: Scientific Reports [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] age Analysis anti-SARS-CoV-2 Anti-spike antibody antibody level Antibody Response baseline BNT162b2 vaccine COVID-19 vaccine decrease domain dose doses Efficacy evaluate female healthy individual IgG IgG antibody IgG level Immunity Immunological response immunosurveillance independent indirect chemiluminescence immunoassay individual induce Infection longitudinal males naïve Protein reactivity recipients respiratory response S-RBD SARS-CoV-2 SARS-CoV-2 vaccine SARS-CoV2 infection Sex SNIBE Steady state Support the vaccine Trigger Vaccine vaccine doses [DOI] 10.1038/s41598-022-12750-z PMC 바로가기 [Article Type] Article
Antibody response to COVID-19 vaccination in patients with lymphoma림프종 환자에서 코로나19 예방접종에 대한 항체 반응Observational Study Published on 2022-05-012022-09-12 Journal: International journal of hematology [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] acute respiratory syndrome anti-S anti-S antibody antibody level Antibody Response CD19 CD4 Cell clinically conducted coronavirus correlated COVID-19 COVID-19 vaccination COVID-19 vaccine Effectiveness Efficacy Factor help IgM Immunoglobulin increased risk interleukin 2 lymphoma lymphoma cell median MONITOR Multivariate analysis Patient Peripheral blood predict prospective observational study Protective receiving receptor SARS-CoV-2 vaccination second dose serum significantly the antibody response the SARS-CoV-2 the vaccine Treatment Vaccine White blood cell [DOI] 10.1007/s12185-022-03305-z PMC 바로가기 [Article Type] Observational Study
Neutralizing antibody responses 300 days after SARS-CoV-2 infection and induction of high antibody titers after vaccinationSARS-CoV-2 감염 300일 후 항체 반응 중화 및 백신 접종 후 고항체 역가 유도Article Published on 2022-05-012022-09-11 Journal: European Journal of Immunology [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] absence Anti-RBD antibodies Anti-RBD antibody antibody antibody level antibody levels Antibody Response Antibody titer Antibody titers Antibody-mediated immunity benefit COVID-19 COVID-19 patient COVID-19 patients COVID-19 vaccination declined detect detectable disease health institution Immunity individual individuals Infection Local Neutralizing antibodies neutralizing antibody Neutralizing antibody titer outbreak PROTECT RBD Receptor binding domain SARS-CoV-2 SARS-CoV-2 ⋅ COVID-19 ⋅ Vaccines ⋅ antibody titers ⋅ waning immunity. SARS-COV-2 infection SARS-CoV-2 spike spike These data vaccinated individual vaccination vaccine dose virus waning immunity [DOI] 10.1002/eji.202149758 PMC 바로가기 [Article Type] Article
Characterizing Kinetics and Avidity of SARS-CoV-2 Antibody Responses in COVID-19 Greek PatientsCOVID-19 그리스 환자에서 SARS-CoV-2 항체 반응의 동력학 및 결합력 특성화Article Published on 2022-04-052022-09-12 Journal: Viruses [Category] COVID19(2023년), SARS, 진단, [키워드] Accuracy analyzed antibody Antibody avidity antibody avidity. antibody level avidity Clinical symptoms Concentration Course COVID-19 COVID-19 patient defined determine Diagnosis examined Hospitalized hospitalized patient IgG IgG kinetics immune response Immunity IMPROVE in both group Infection infections Kinetics maturation men overcome Patient Reinfection response risk SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection serological Sex significantly Variability women [DOI] 10.3390/v14040758 PMC 바로가기 [Article Type] Article
Population differences in antibody response to SARS-CoV-2 infection and BNT162b2 vaccinationSARS-CoV-2 감염과 BNT162b2 백신 접종에 대한 항체 반응의 인구 차이Article Published on 2022-04-012022-09-12 Journal: FASEB journal : official publication of the Federa [Category] COVID19(2023년), SARS, 진단, [키워드] age age and sex anti-SARS-CoV-2 Anti-viral immunity antibodies antibody antibody level Antibody Response BNT162b2 Cohort complex composed Concentration correlated COVID-19 COVID-19 patient COVID-19 symptoms COVID-19 vaccine decrease elicited Factor humoral IgG antibodies infected with SARS-CoV-2 Infection magnitude maintain males of BNT162b2 participant Population primary determinant recipient recipients repeated SARS-CoV-2 SARS-COV-2 infection serum antibodies serum sample severity Sex spike protein RBD Support susceptible vaccination Vaccine [DOI] 10.1096/fj.202101492R PMC 바로가기 [Article Type] Article